Generic Seroquel Availability

See also: Generic Seroquel XR

Seroquel is a brand name of quetiapine, approved by the FDA in the following formulation(s):

SEROQUEL (quetiapine fumarate - tablet;oral)

  • Manufacturer: ASTRAZENECA
    Approval date: September 26, 1997
    Strength(s): EQ 25MG BASE [RLD] [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB]
  • Manufacturer: ASTRAZENECA
    Approval date: July 26, 2000
    Strength(s): EQ 300MG BASE [RLD] [AB]
  • Manufacturer: ASTRAZENECA
    Approval date: October 4, 2005
    Strength(s): EQ 50MG BASE [AB], EQ 400MG BASE [AB]

Has a generic version of Seroquel been approved?

Yes. The following products are equivalent to Seroquel:

quetiapine fumarate tablet;oral

  • Manufacturer: ACCORD HLTHCARE
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: ACTAVIS GRP PTC
    Approval date: February 27, 2013
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: ALKEM LABS LTD
    Approval date: February 12, 2013
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: APOTEX INC
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: AUROBINDO PHARMA LTD
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: DR REDDYS LABS LTD
    Approval date: March 27, 2012
    Strength(s): EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB], EQ 25MG BASE [AB], EQ 50MG BASE [AB]
  • Manufacturer: JUBILANT GENERICS
    Approval date: November 26, 2013
    Strength(s): EQ 25MG BASE [AB]
  • Manufacturer: LUPIN LTD
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: MYLAN PHARMS INC
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB]
  • Manufacturer: ROXANE
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: SANDOZ
    Approval date: December 14, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: SUN PHARMA GLOBAL
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: TEVA PHARMS
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]
  • Manufacturer: TORRENT PHARMS LTD
    Approval date: March 27, 2012
    Strength(s): EQ 25MG BASE [AB], EQ 50MG BASE [AB], EQ 100MG BASE [AB], EQ 200MG BASE [AB], EQ 300MG BASE [AB], EQ 400MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Seroquel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Seroquel.

Glossary

TermDefinition
Drug PatentA drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation.
Drug ExclusivityExclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant.
RLDA Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart.
ABProducts meeting necessary bioequivalence requirements. Multisource drug products listed under the same heading (i.e., identical active ingredients(s), dosage form, and route(s) of administration) and having the same strength (see Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (i.e., AB1, AB2, AB3, etc.). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against.
Hide
(web3)